ARTOS - Avelox in Routine Treatment of Complicated Skin and Skin Structure Infections.

Trial Profile

ARTOS - Avelox in Routine Treatment of Complicated Skin and Skin Structure Infections.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Nov 2012

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Bacterial infections; Skin infections
  • Focus Therapeutic Use
  • Acronyms ARTOS
  • Sponsors Bayer
  • Most Recent Events

    • 02 Dec 2011 Primary endpoint identified as (clinical response rate) and (drug utilisation) as reported by ClinicalTrials.gov.
    • 21 Nov 2011 Additional location added as reported by ClinicalTrials.gov.
    • 28 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top